# New Animal Drugs; Butorphanol; Doxapram; Triamcinolone; Tylosin
> **Food and Drug Administration** · Final rule. · Published 2012-10-03 · Effective 2012-10-15 · 77 FR 60301
## Document
- **Document number:** 2012-24331
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 77 FR 60301
- **CFR reference:** 21 CFR 510
- **Publication date:** 2012-10-03
- **Effective date:** 2012-10-15
- **HHS docket:** Docket No. FDA-2012-N-0002
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal approval of a new animal drug application (NADA) and three abbreviated new animal drug applications (ANADAs) at the sponsors' request because the products are no longer manufactured or marketed.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2012/10/03/2012-24331/new-animal-drugs-butorphanol-doxapram-triamcinolone-tylosin)
---
*AI Analytics · CC0 1.0*